Skip to content

Vasoactive intestinal peptide (VIP, aviptadil) studies: 420 papers with results

Page 7 of 9

  1. Role of tear vasoactive intestinal peptide on dry eyes after laser keratorefractive surgery.

    Kang Y · BMC ophthalmology · 2023

    Measured the body's own Vasoactive intestinal peptide (VIP, aviptadil) · 3 results

  2. The effects of serotonin on the differentiation of neurons producing vasoactive intestinal polypeptide in the suprachiasmatic nucleus of the rat.

    Mirochnik VV · Neuroscience and behavioral physiology · 2003

    Measured the body's own Vasoactive intestinal peptide (VIP, aviptadil) · 3 results

  3. Regional distribution of vasoactive intestinal peptide immunoreactivity in the brain of salmon, trout and carp.

    Canciglia P · Biological signals · 1995

    Measured the body's own Vasoactive intestinal peptide (VIP, aviptadil) · 3 results

  4. Comparison of immunohistochemical localization of [Met5] enkephalin-Arg6-Gly7-Leu8, vasoactive intestinal polypeptide and tyrosine hydroxylase in the major pelvic ganglion of the rat.

    Karhula T · Neuroscience · 1993

    Measured the body's own Vasoactive intestinal peptide (VIP, aviptadil) · 3 results

  5. Substance P and vasoactive intestinal peptide levels in middle ear effusions of children.

    Eyigor H · Acta oto-laryngologica · 2012

    Measured the body's own Vasoactive intestinal peptide (VIP, aviptadil) · 3 results

  6. The effect of dietary sodium on the concentrations of vasoactive intestinal peptide in plasma and lung.

    Ye VZ · Chest · 1995

    Measured the body's own Vasoactive intestinal peptide (VIP, aviptadil) · 3 results

  7. Pituitary adenylate cyclase activating peptide: a novel vasoactive intestinal peptide-like neuropeptide in the gut.

    Sundler F · Neuroscience · 1992

    Measured the body's own Vasoactive intestinal peptide (VIP, aviptadil) · 2 results

  8. Quantification of neuropeptides (calcitonin gene-related peptide, substance P, neurokinin A, neuropeptide Y and vasoactive intestinal polypeptide) expressed in healthy and inflamed human dental pulp.

    Caviedes-Bucheli J · International endodontic journal · 2006

    Measured the body's own Vasoactive intestinal peptide (VIP, aviptadil) · 2 results

  9. Gender-specific apposition between vasoactive intestinal peptide-containing axons and gonadotrophin-releasing hormone-producing neurons in the rat.

    Horvath TL · Brain research · 1998

    Measured the body's own Vasoactive intestinal peptide (VIP, aviptadil) · 2 results

  10. Vasoactive intestinal polypeptide-like immunoreactive nerves in diabetic penis. A comparison between streptozotocin-treated rats and man.

    Crowe R · Diabetes · 1983

    Measured the body's own Vasoactive intestinal peptide (VIP, aviptadil) · 2 results

  11. Ageing and the diurnal expression of mRNAs for vasoactive intestinal peptide and for the VPAC2 and PAC1 receptors in the suprachiasmatic nucleus of male rats.

    Kalló I · Journal of neuroendocrinology · 2004

    Measured the body's own Vasoactive intestinal peptide (VIP, aviptadil) · 2 results

  12. Increased expression of vasoactive intestinal polypeptide in cultured myenteric neurons from adult rat small intestine.

    Lin Z · Autonomic neuroscience : basic & clinical · 2003

    Measured the body's own Vasoactive intestinal peptide (VIP, aviptadil) · 2 results

  13. Vasoactive intestinal peptide concentrations in turkey hypophysial portal blood differ across the reproductive cycle.

    Youngren O · General and comparative endocrinology · 1996

    Measured the body's own Vasoactive intestinal peptide (VIP, aviptadil) · 2 results

  14. Prolonged treatment with transcutaneous electrical nerve stimulation (TENS) modulates neuro-gastric motility and plasma levels of vasoactive intestinal peptide (VIP), motilin and interleukin-6 (IL-6) in systemic sclerosis.

    McNearney TA · Clinical and experimental rheumatology · 2013

    Measured the body's own Vasoactive intestinal peptide (VIP, aviptadil) · 2 results

  15. Effects of postweaning social isolation and re-socialization on the expression of vasoactive intestinal peptide (VIP) and dendritic development in the medial prefrontal cortex of the rat.

    Pascual R · Acta neurobiologiae experimentalis · 2006

    Measured the body's own Vasoactive intestinal peptide (VIP, aviptadil) · 2 results

  16. Vasoactive intestinal polypeptide precursor mRNA exhibits diurnal variation in the rat suprachiasmatic nuclei.

    Yang J · Brain research. Molecular brain research · 1993

    Measured the body's own Vasoactive intestinal peptide (VIP, aviptadil) · 2 results

  17. Lactation elevates vasoactive intestinal peptide messenger ribonucleic acid in rat suprachiasmatic nucleus.

    Gozes I · Endocrinology · 1989

    Measured the body's own Vasoactive intestinal peptide (VIP, aviptadil) · 2 results

  18. Release of regulatory gut peptides somatostatin, neurotensin and vasoactive intestinal peptide by acid and hyperosmolal solutions in the intestine in conscious rats.

    Rudholm T · Regulatory peptides · 2009

    Measured the body's own Vasoactive intestinal peptide (VIP, aviptadil) · 2 results

  19. Timed hypocaloric food restriction alters the synthesis and expression of vasopressin and vasoactive intestinal peptide in the suprachiasmatic nucleus.

    Andrade JP · Brain research · 2004

    Measured the body's own Vasoactive intestinal peptide (VIP, aviptadil) · 2 results

  20. Patients with lower motor spinal cord lesion: a decrease of vasoactive intestinal polypeptide, calcitonin gene-related peptide and substance P, but not neuropeptide Y and somatostatin-immunoreactive nerves in the detrusor muscle of the bladder.

    Crowe R · The Journal of urology · 1991

    Measured the body's own Vasoactive intestinal peptide (VIP, aviptadil) · 2 results

  21. Basal hyperchlorhydria and its relation to the plasma concentrations of secretin, vasoactive intestinal polypeptide (VIP) and gastrin during prolonged strain.

    Oektedalen O · Regulatory peptides · 1983

    Measured the body's own Vasoactive intestinal peptide (VIP, aviptadil) · 2 results

  22. Vasopeptidase inhibition reverses myocardial vasoactive intestinal peptide depletion and decreases fibrosis in salt sensitive hypertension.

    Ye VZ · European journal of pharmacology · 2004

    Measured the body's own Vasoactive intestinal peptide (VIP, aviptadil) · 2 results

  23. Vasoactive intestinal peptide gene: putative mechanism of information storage at the RNA level.

    Gozes I · Journal of neurochemistry · 1987

    Measured the body's own Vasoactive intestinal peptide (VIP, aviptadil) · 2 results

  24. The effect of parenteral and enteral nutrition on portal and systemic immunoreactivities of gastrin, glucagon and vasoactive intestinal polypeptide (VIP).

    Gimmon Z · Annals of surgery · 1982

    Measured the body's own Vasoactive intestinal peptide (VIP, aviptadil) · 2 results

  25. Changes in vasoactive intestinal peptide and arginine vasopressin expression in the suprachiasmatic nucleus of the rat brain following footshock stress.

    Handa RJ · Neuroscience letters · 2007

    Measured the body's own Vasoactive intestinal peptide (VIP, aviptadil) · 2 results

  26. Expression of mRNA for vasoactive intestinal peptide in normal human colon and during inflammation.

    Schulte-Bockholt A · Molecular and cellular biochemistry · 1995

    Measured the body's own Vasoactive intestinal peptide (VIP, aviptadil) · 2 results

  27. Multiple peptide immunoreactivities in the nervous system of Aeschna cyanea (Insecta, Odonata). An immunohistochemical study using antisera to cholecystokinin octapeptide, somatoliberin, vasoactive intestinal peptide, motilin and proctolin.

    Andriès JC · Histochemistry · 1991

    Measured the body's own Vasoactive intestinal peptide (VIP, aviptadil) · 2 results

  28. The plasma concentrations of secretin and vasoactive intestinal polypeptide (VIP) after long-term, strenuous exercise.

    Oktedalen O · European journal of applied physiology and occupational physiology · 1983

    Measured the body's own Vasoactive intestinal peptide (VIP, aviptadil) · 2 results

  29. No changes in the number of vasoactive intestinal polypeptide (VIP)-expressing neurons in the suprachiasmatic nucleus of homosexual men; comparison with vasopressin-expressing neurons.

    Zhou JN · Brain research · 1995

    Measured the body's own Vasoactive intestinal peptide (VIP, aviptadil) · 2 results

  30. Focal, but not global, cerebral ischaemia causes loss of myenteric neurons and upregulation of vasoactive intestinal peptide in mouse ileum.

    Cheng X · International journal of experimental pathology · 2018

    Measured the body's own Vasoactive intestinal peptide (VIP, aviptadil) · 2 results

  31. Vasoactive intestinal polypeptide (VIP) secretion and refractory diarrhea in patients with AIDS or AIDS-related complex (ARC).

    Manfredi R · Scandinavian journal of infectious diseases · 1994

    Measured the body's own Vasoactive intestinal peptide (VIP, aviptadil) · 2 results

  32. A comparative study of the effects of neonatal androgenization and estrogenization on vasoactive intestinal peptide levels in the anterior pituitary and the hypothalamus of adult female rats.

    Watanobe H · Neuroendocrinology · 1992

    Measured the body's own Vasoactive intestinal peptide (VIP, aviptadil) · 2 results

  33. Immunocytochemical localization of vasoactive intestinal polypeptide (VIP) in the brain of the little brown bat (Myotis lucifugus).

    Laemle LK · Journal of neurocytology · 1988

    Measured the body's own Vasoactive intestinal peptide (VIP, aviptadil) · 2 results

  34. Effect of intracanal medicaments on matrix metalloproteinase-9 and vasoactive intestinal peptide secretion in periapical lesions of re-treated canals: a randomized controlled clinical study.

    Özdemir MB · Clinical oral investigations · 2019

    Measured the body's own Vasoactive intestinal peptide (VIP, aviptadil) · 2 results

  35. Immunoreactive vasoactive intestinal polypeptide in acinic cell carcinoma of the parotid gland.

    Hayashi Y · Cancer · 1987

    Measured the body's own Vasoactive intestinal peptide (VIP, aviptadil) · 2 results

  36. Elcatonin raises levels of vasoactive intestinal peptide in human plasma.

    Takeyama M · The Journal of pharmacy and pharmacology · 1996

    Measured the body's own Vasoactive intestinal peptide (VIP, aviptadil) · 2 results

  37. Expression of vasoactive intestinal peptide, substance P and bombesin-flanking peptide in nasal polyps.

    Kühn AG · ORL; journal for oto-rhino-laryngology and its related specialties · 1996

    Measured the body's own Vasoactive intestinal peptide (VIP, aviptadil) · 2 results

  38. Decreases in substance P and vasoactive intestinal peptide concentrations in plasma of stroke-prone spontaneously hypertensive rats.

    Mori K · Japanese heart journal · 1993

    Measured the body's own Vasoactive intestinal peptide (VIP, aviptadil) · 2 results

  39. Lack of circadian rhythm of plasma concentrations of vasoactive intestinal peptide in patients with orthotopic heart transplants.

    Cugini P · British heart journal · 1993

    Measured the body's own Vasoactive intestinal peptide (VIP, aviptadil) · 2 results

  40. Vasoactive intestinal peptide-associated inhibition of stimulated gastric secretion. II. Inhibition of pentagastrin-stimulated gastric secretion.

    Escourrou J · American journal of surgery · 1980

    Measured the body's own Vasoactive intestinal peptide (VIP, aviptadil) · 2 results

  41. Vasoactive intestinal polypeptide gene expression is characteristically higher in opossum gastrointestinal sphincters.

    Bandyopadhyay A · Gastroenterology · 1994

    Measured the body's own Vasoactive intestinal peptide (VIP, aviptadil) · 2 results

  42. A comparative study of the localization of vasoactive intestinal peptide- and substance P-like immunoreactivities in the submandibular salivary glands of mice.

    Letić-Gavrilović A · Shika Kiso Igakkai zasshi = Japanese journal of oral biology · 1989

    Measured the body's own Vasoactive intestinal peptide (VIP, aviptadil) · 2 results

  43. Concentration of substance P, neurokinin A, calcitonin gene-related peptide, neuropeptide Y and vasoactive intestinal polypeptide in synovial fluid from knee joints in patients suffering from rheumatoid arthritis.

    Larsson J · Scandinavian journal of rheumatology · 1991

    Measured the body's own Vasoactive intestinal peptide (VIP, aviptadil) · 1 result

  44. Changes in the somatostatin, substance P and vasoactive intestinal polypeptide content of the gastrointestinal tract following streptozotocin-induced diabetes in the rat.

    Ballmann M · Diabetologia · 1985

    Measured the body's own Vasoactive intestinal peptide (VIP, aviptadil) · 1 result

  45. Human brain contains vasopressin and vasoactive intestinal polypeptide neuronal subpopulations in the suprachiasmatic region.

    Stopa EG · Brain research · 1984

    Measured the body's own Vasoactive intestinal peptide (VIP, aviptadil) · 1 result

  46. Sensory stimulation (acupuncture) increases the release of vasoactive intestinal polypeptide in the saliva of xerostomia sufferers.

    Dawidson I · Neuropeptides · 1998

    Measured the body's own Vasoactive intestinal peptide (VIP, aviptadil) · 1 result

  47. The control of circadian rhythms and the levels of vasoactive intestinal peptide mRNA in the suprachiasmatic nucleus are altered in spontaneously hypertensive rats.

    Peters RV · Brain research · 1994

    Measured the body's own Vasoactive intestinal peptide (VIP, aviptadil) · 1 result

  48. Vasoactive intestinal polypeptide and its receptor changes in human temporal lobe epilepsy.

    de Lanerolle NC · Brain research · 1995

    Measured the body's own Vasoactive intestinal peptide (VIP, aviptadil) · 4 results

  49. Cholecystokinin, vasoactive intestinal peptide and peptide histidine methionine responses to feeding in anorexia nervosa.

    Harty RF · Regulatory peptides · 1991

    Measured the body's own Vasoactive intestinal peptide (VIP, aviptadil) · 1 result

  50. Distribution of vasoactive intestinal peptide (VIP) and its binding sites in labial salivary glands in Sjögren's syndrome and in normal controls.

    Törnwall J · Clinical and experimental rheumatology · 1994

    Measured the body's own Vasoactive intestinal peptide (VIP, aviptadil) · 3 results

How PepBank reports evidence